87 related articles for article (PubMed ID: 8960743)
21. Positron emission tomographic scanning demonstrates a presynaptic dopaminergic lesion in Lytico-Bodig. The amyotrophic lateral sclerosis-parkinsonism-dementia complex of Guam.
Snow BJ; Peppard RF; Guttman M; Okada J; Martin WR; Steele J; Eisen A; Carr G; Schoenberg B; Calne D
Arch Neurol; 1990 Aug; 47(8):870-4. PubMed ID: 2375693
[TBL] [Abstract][Full Text] [Related]
22. An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome.
Ruottinen HM; Partinen M; Hublin C; Bergman J; Haaparanta M; Solin O; Rinne JO
Neurology; 2000 Jan; 54(2):502-4. PubMed ID: 10668725
[TBL] [Abstract][Full Text] [Related]
23. Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene.
Hilker R; Klein C; Ghaemi M; Kis B; Strotmann T; Ozelius LJ; Lenz O; Vieregge P; Herholz K; Heiss WD; Pramstaller PP
Ann Neurol; 2001 Mar; 49(3):367-76. PubMed ID: 11261512
[TBL] [Abstract][Full Text] [Related]
24. [Familial amyotrophic lateral sclerosis (FALS) with a novel SOD1 gene mutation: a clinicopathological study].
Kawamata C; Morita M; Shibata N; Nakano I
Rinsho Shinkeigaku; 2007 May; 47(5):211-6. PubMed ID: 17585602
[TBL] [Abstract][Full Text] [Related]
25. [On intra-familial clinical diversities of a familial amyotrophic lateral sclerosis with a point mutation of Cu/Zn superoxide dismutase (Asn 86-Ser].
Maeda T; Kurahashi K; Matsunaga M; Inoue K; Inoue M
No To Shinkei; 1997 Sep; 49(9):847-51. PubMed ID: 9311004
[TBL] [Abstract][Full Text] [Related]
26. Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene.
Cudkowicz ME; McKenna-Yasek D; Chen C; Hedley-Whyte ET; Brown RH
Ann Neurol; 1998 Jun; 43(6):703-10. PubMed ID: 9629839
[TBL] [Abstract][Full Text] [Related]
27. Variable clinical symptoms in familial amyotrophic lateral sclerosis with a novel point mutation in the Cu/Zn superoxide dismutase gene.
Ikeda M; Abe K; Aoki M; Sahara M; Watanabe M; Shoji M; St George-Hyslop PH; Hirai S; Itoyama Y
Neurology; 1995 Nov; 45(11):2038-42. PubMed ID: 7501156
[TBL] [Abstract][Full Text] [Related]
28. Oxidative stress and metal content in blood and cerebrospinal fluid of amyotrophic lateral sclerosis patients with and without a Cu, Zn-superoxide dismutase mutation.
Ihara Y; Nobukuni K; Takata H; Hayabara T
Neurol Res; 2005 Jan; 27(1):105-8. PubMed ID: 15829169
[TBL] [Abstract][Full Text] [Related]
29. TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation.
Tan CF; Eguchi H; Tagawa A; Onodera O; Iwasaki T; Tsujino A; Nishizawa M; Kakita A; Takahashi H
Acta Neuropathol; 2007 May; 113(5):535-42. PubMed ID: 17333220
[TBL] [Abstract][Full Text] [Related]
30. A frequent ala 4 to val superoxide dismutase-1 mutation is associated with a rapidly progressive familial amyotrophic lateral sclerosis.
Rosen DR; Bowling AC; Patterson D; Usdin TB; Sapp P; Mezey E; McKenna-Yasek D; O'Regan J; Rahmani Z; Ferrante RJ
Hum Mol Genet; 1994 Jun; 3(6):981-7. PubMed ID: 7951249
[TBL] [Abstract][Full Text] [Related]
31. Decreased striatal monoaminergic terminals in Huntington disease.
Bohnen NI; Koeppe RA; Meyer P; Ficaro E; Wernette K; Kilbourn MR; Kuhl DE; Frey KA; Albin RL
Neurology; 2000 May; 54(9):1753-9. PubMed ID: 10802780
[TBL] [Abstract][Full Text] [Related]
32. Copper/zinc superoxide dismutase 1 and sporadic amyotrophic lateral sclerosis: analysis of 155 cases and identification of a novel insertion mutation.
Jackson M; Al-Chalabi A; Enayat ZE; Chioza B; Leigh PN; Morrison KE
Ann Neurol; 1997 Nov; 42(5):803-7. PubMed ID: 9392581
[TBL] [Abstract][Full Text] [Related]
33. Young-onset Parkinson disease with and without parkin gene mutations: a fluorodopa F 18 positron emission tomography study.
Thobois S; Ribeiro MJ; Lohmann E; Dürr A; Pollak P; Rascol O; Guillouet S; Chapoy E; Costes N; Agid Y; Remy P; Brice A; Broussolle E;
Arch Neurol; 2003 May; 60(5):713-8. PubMed ID: 12756135
[TBL] [Abstract][Full Text] [Related]
34. Glycation proceeds faster in mutated Cu, Zn-superoxide dismutases related to familial amyotrophic lateral sclerosis.
Takamiya R; Takahashi M; Myint T; Park YS; Miyazawa N; Endo T; Fujiwara N; Sakiyama H; Misonou Y; Miyamoto Y; Fujii J; Taniguchi N
FASEB J; 2003 May; 17(8):938-40. PubMed ID: 12626432
[TBL] [Abstract][Full Text] [Related]
35. Recent advances in research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 gene mutations: neuronal Lewy body-like hyaline inclusions and astrocytic hyaline inclusions.
Kato S; Saito M; Hirano A; Ohama E
Histol Histopathol; 1999 Jul; 14(3):973-89. PubMed ID: 10425565
[TBL] [Abstract][Full Text] [Related]
36. [Familial amyotrophic lateral sclerosis associated with mutant Cu/Zn superoxide dismutase as a conformational disease].
Koide T; Igarashi S; Kikugawa K; Nakano R; Inuzuka T; Tsuji S; Yamada M; Takahashi H
Rinsho Shinkeigaku; 1999 Dec; 39(12):1283-4. PubMed ID: 10791098
[TBL] [Abstract][Full Text] [Related]
37. Kinetic stability of Cu/Zn superoxide dismutase is dependent on its metal ligands: implications for ALS.
Lynch SM; Boswell SA; Colón W
Biochemistry; 2004 Dec; 43(51):16525-31. PubMed ID: 15610047
[TBL] [Abstract][Full Text] [Related]
38. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide.
Yim MB; Kang JH; Yim HS; Kwak HS; Chock PB; Stadtman ER
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5709-14. PubMed ID: 8650157
[TBL] [Abstract][Full Text] [Related]
39. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
40. [Presynaptic nigrostriatal function in Parkinson disease and Parkinson-plus syndromes. Comparative studies using positron emission tomography with L-6-(18F)fluorodopa].
Cordes M; Poewe W
Nervenarzt; 1994 Oct; 65(10):696-9. PubMed ID: 7808568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
